0001493152-24-012832.txt : 20240402 0001493152-24-012832.hdr.sgml : 20240402 20240402165841 ACCESSION NUMBER: 0001493152-24-012832 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240329 FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hakim Nasrat A CENTRAL INDEX KEY: 0001583742 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15697 FILM NUMBER: 24815293 MAIL ADDRESS: STREET 1: C/O ELITE PHARMACEUTICALS, INC. STREET 2: 165 LUDLOW AVE. CITY: NORTHVALE STATE: NJ ZIP: 07647 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/ CENTRAL INDEX KEY: 0001053369 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 223542636 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 BUSINESS PHONE: 2017502646 MAIL ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 FORMER COMPANY: FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/ DATE OF NAME CHANGE: 19980121 4 1 ownership.xml X0508 4 2024-03-29 0 0001053369 ELITE PHARMACEUTICALS INC /NV/ ELTP 0001583742 Hakim Nasrat A C/O ELITE PHARMACEUTICALS, INC., 165 LUDLOW AVE. NORTHVALE NJ 07647 1 1 1 0 CEO, President 0 Common Stock 2024-03-29 4 A 0 49534368 0.00 A 216649250 D Common Stock 2700000 I by IRA Common Stock 2223147 I by Kristine Hakim Shares issued in settlement of compensation owed to the Reporting Person pursuant to his Employment Agreement with the issuer, dated August 1, 2013, as amended. Nasrat A Hakim 2024-04-02